428 related articles for article (PubMed ID: 15156433)
1. Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries.
Friedland G; Abdool Karim S; Abdool Karim Q; Lalloo U; Jack C; Gandhi N; El Sadr W
Clin Infect Dis; 2004 Jun; 38 Suppl 5():S421-8. PubMed ID: 15156433
[TBL] [Abstract][Full Text] [Related]
2. From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and in Boston.
Behforouz HL; Farmer PE; Mukherjee JS
Clin Infect Dis; 2004 Jun; 38 Suppl 5():S429-36. PubMed ID: 15156434
[TBL] [Abstract][Full Text] [Related]
3. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and management challenges for childhood tuberculosis in the era of HIV.
Marais BJ; Graham SM; Cotton MF; Beyers N
J Infect Dis; 2007 Aug; 196 Suppl 1():S76-85. PubMed ID: 17624829
[TBL] [Abstract][Full Text] [Related]
5. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.
Kwara A; Flanigan TP; Carter EJ
Int J Tuberc Lung Dis; 2005 Mar; 9(3):248-57. PubMed ID: 15786886
[TBL] [Abstract][Full Text] [Related]
6. BHIVA treatment guidelines for tuberculosis (TB)/HIV infection 2005.
Pozniak AL; Miller RF; Lipman MC; Freedman AR; Ormerod LP; Johnson MA; Collins S; Lucas SB;
HIV Med; 2005 Jul; 6 Suppl 2():62-83. PubMed ID: 16011537
[No Abstract] [Full Text] [Related]
7. Managing TB in the 21st century: existing and novel drug therapies.
Guy ES; Mallampalli A
Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical care for HIV patients on directly observed therapy.
Foisy MM; Akai PS
Ann Pharmacother; 2004 Apr; 38(4):550-6. PubMed ID: 14990778
[TBL] [Abstract][Full Text] [Related]
9. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of antiretrovirals with rifampicin: crucial issues for high-burden countries.
Maartens G; Decloedt E; Cohen K
Antivir Ther; 2009; 14(8):1039-43. PubMed ID: 20032533
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.
Williams BG; Dye C
Science; 2003 Sep; 301(5639):1535-7. PubMed ID: 12920302
[TBL] [Abstract][Full Text] [Related]
12. Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection.
El-Sony AI; Khamis AH; Enarson DA; Baraka O; Mustafa SA; Bjune G
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1058-66. PubMed ID: 12546113
[TBL] [Abstract][Full Text] [Related]
13. Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.
McIlleron H; Meintjes G; Burman WJ; Maartens G
J Infect Dis; 2007 Aug; 196 Suppl 1():S63-75. PubMed ID: 17624828
[TBL] [Abstract][Full Text] [Related]
14. TB and HIV: joint problems, joint solutions?
Elzinga G; Nunn P
Bull World Health Organ; 2002; 80(6):469-70. PubMed ID: 12132004
[No Abstract] [Full Text] [Related]
15. HIV infection-related tuberculosis: clinical manifestations and treatment.
Sterling TR; Pham PA; Chaisson RE
Clin Infect Dis; 2010 May; 50 Suppl 3():S223-30. PubMed ID: 20397952
[TBL] [Abstract][Full Text] [Related]
16. The growing shadow of tuberculosis.
Nary G
J Int Assoc Physicians AIDS Care; 1995 Apr; 1(3):26-7. PubMed ID: 11362486
[TBL] [Abstract][Full Text] [Related]
17. Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients.
García de Olalla P; Martínez-González MA; Caylà JA; Jansà JM; Iglesias B; Guerrero R; Marco A; Gatell JM; Ocaña I;
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1051-7. PubMed ID: 12546112
[TBL] [Abstract][Full Text] [Related]
18. HIV-associated tuberculosis: diagnostic and treatment challenges.
El-Sadr WM; Tsiouris SJ
Semin Respir Crit Care Med; 2008 Oct; 29(5):525-31. PubMed ID: 18810685
[TBL] [Abstract][Full Text] [Related]
19. Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings.
Lawn SD; Ayles H; Egwaga S; Williams B; Mukadi YD; Santos Filho ED; Godfrey-Faussett P; Granich RM; Harries AD
Int J Tuberc Lung Dis; 2011 Mar; 15(3):287-95. PubMed ID: 21333094
[TBL] [Abstract][Full Text] [Related]
20. Review editorial: prevention of tuberculosis in resource-poor countries with increasing access to highly active antiretroviral treatment.
Apers L; Lynen L; Worodria W; Colebunders R
Trop Med Int Health; 2005 Dec; 10(12):1209-14. PubMed ID: 16359399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
